Bauer A, Berben P, Chakravarthi SS, Chattorraj S, Garg A, Gourdon B, et al. Current state and opportunities with long-acting injectables: industry perspectives from the innovation and quality consortium “long-acting injectables” working group. Pharm Res. Springer. 2023:1–31.

Bassand C, Villois A, Gianola L, Laue G, Ramazani F, Riebesehl B, et al. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities. Expert Opin Drug Deliv. 2022:1265–83.

Bettonte S, Berton M, Marzolini C. What is the significance of the pharmacokinetic profile and potential drug–drug interactions of long-acting intramuscular cabotegravir and rilpivirine? Expert Opin Drug Metab Toxicol. 2023;19(5):243–7.

Article  CAS  PubMed  Google Scholar 

Madabushi R, Seo P, Zhao L, Tegenge M, Zhu H. Review: role of model-informed drug development approaches in the lifecycle of drug development and regulatory decision-making. Pharm Res. Springer. 2022;39(8):1669–80.

Shah JC, Hong J. Model for long acting injectables (depot formulation) based on pharmacokinetics and physical chemical properties. AAPS J. 2022;24(3):44.

Johnson AR, Ballard JE, Leithead A, Miller C, Faassen F, Zang X, et al. A retrospective analysis of preclinical and clinical pharmacokinetics from administration of long-acting aqueous suspensions. Pharm Res. 2023:1–16.

Bassand C, Villois A, Gianola L, Laue G, Ramazani F, Riebesehl B, et al. Smart design of patient-centric long-acting products: from preclinical to marketed pipeline trends and opportunities. Expert Opin Drug Deliv. 2022:1265–83.

Lou H, Hageman MJ. Development of an in vitro system to emulate an in vivo subcutaneous environment: small molecule drug assessment. Mol Pharm. 2022:4017–25.

Arya V, Hodowanec AC, Troy SB, Struble KA. Long-acting formulations for the prevention and treatment of human immunodeficiency virus (HIV)-1 infection: strategic leveraging and integration of multidisciplinary knowledge to advance public health. Clin Infect Dis. 2022;75:S498-501.

Article  PubMed  Google Scholar 

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Human immunodeficiency virus-1 infection: developing systemic drug products for pre-exposure prophylaxis guidance for industry. 2019.

Li W, Tang J, Lee D, Tice TR, Schwendeman SP, Prausnitz MR. Clinical translation of long-acting drug delivery formulations. Nat Rev Mater. 2022;7(5):406–20.

Article  Google Scholar 

Chen Z, He J, Qi J, Zhu Q, Wu W, Lu Y. Long-acting microneedles: a progress report of the state-of-the-art techniques. Drug Discov Today. 2020;25:1462–8.

Article  CAS  PubMed  Google Scholar 

Croxatto HB. Progestin implants. Steroids. 2000;65:681–5.

Article  CAS  PubMed  Google Scholar 

Nkanga CI, Fisch A, Rad-Malekshahi M, Romic MD, Kittel B, Ullrich T, et al. Clinically established biodegradable long acting injectables: an industry perspective. Adv Drug Deliv Rev. Elsevier B.V.; 2020. p. 19–46.

Magnusson MO, Samtani MN, Plan EL, Jonsson EN, Rossenu S, Vermeulen A, et al. Population pharmacokinetics of a novel once-every 3 months intramuscular formulation of paliperidone palmitate in patients with schizophrenia. Clin Pharmacokinet. 2017;56:421–33.

Article  CAS  PubMed  Google Scholar 

Rhee Y-SC-WPPPD and HMM. Sustained-release injectable drug delivery. Pharm. Technol. 2010;6:8–13.

Nguyen VTT, Darville N, Vermeulen A. Pharmacokinetics of long-acting aqueous nano-/microsuspensions after intramuscular administration in different animal species and humans - a review. AAPS J. NLM (Medline). 2023;25(1):4.

Guo X, Zhang M, Guo Y, Liu H, Yang B, Gou J, et al. Impact of jet pulverization and wet milling techniques on properties of aripiprazole long-acting injection and absorption mechanism research in vivo. Int J Pharm. 2022;612:121300

Darville N, Van Heerden M, Mariën D, De Meulder M, Rossenu S, Vermeulen A, et al. The effect of macrophage and angiogenesis inhibition on the drug release and absorption from an intramuscular sustained-release paliperidone palmitate suspension. J Control Release. 2016;230:95–108.

Article  CAS  PubMed  Google Scholar 

Chamanza R, Darville N, van Heerden M, de Jonghe S. Comparison of the local tolerability to 5 long-acting drug nanosuspensions with different stabilizing excipients, following a single intramuscular administration in the rat. Toxicol Pathol. 2018;46:85–100.

Article  CAS  PubMed  Google Scholar 

Ahsan F, Rivas IP, Khan MA, Torres Suarez AI. Targeting to macrophages: role of physicochemical properties of particulate carriers-liposomes and microspheres-on the phagocytosis by macrophages. J Controll Release. 2002;79:9–40.

Article  Google Scholar 

Ballard BE. Biopharmaceutical considerations in subcutaneous and intramuscular drug administration. J Pharm Sci. 1968;57:357–78.

Article  CAS  PubMed  Google Scholar 

Zuidema J, PFAJM and DGSMJE. Release and absorption rate aspects of intramuscularly injected pharmaceuticals. Int J Pharm. 1988;47:1–12.

Nguyen V, Bevernage J, Darville N, Tistaert C, Van Bocxlaer J, Rossenu S, et al. Linking in vitro intrinsic dissolution rate and thermodynamic solubility with pharmacokinetic profiles of bedaquiline long-acting aqueous microsuspensions in rats. Mol Pharm. 2021;18:952–65.

Article  CAS  PubMed  Google Scholar 

Jucker BM, Alsaid H, Rambo M, Lenhard SC, Hoang B, Xie F, et al. Multimodal imaging approach to examine biodistribution kinetics of cabotegravir (GSK1265744) long acting parenteral formulation in rat. J Control Release. 2017;268:102–12.

Article  CAS  PubMed  Google Scholar 

Medlicott NJ, Waldron NA, Foster TP. Sustained release veterinary parenteral products. Adv Drug Deliv Rev. 2004;56:1345–65.

Article  CAS  PubMed  Google Scholar 

McDowell A and NJM. Anatomy and physiology of the injection site: implications for extended release parenteral systems. Long acting injections and implants. 2012;57–71.

Anderson JM, Niven H, Pelagalli J, Olanoff LS, Jones RD. The role of the fibrous capsule in the function of implanted drug-polymer sustained release systems. J Biomed Mater Res. 1981;15(6):889–902.

Article  CAS  PubMed  Google Scholar 

Hirano KTI and HY. Studies on the absorption of practically water-insoluble drugs following injection. II. Intramuscular absorption from aqueous suspensions in rats. Chem Pharm Bull. 1981;29:817–27.

Zuidema J, Kadir F, Titulaer HAC, Oussoren C. Release and absorption rates of intramuscularly and subcutaneously injected pharmaceuticals (II). Int J Pharm. 1994;105:189–207.

Article  CAS  Google Scholar 

Van den Mooter G, De Meulder M, Darville N, De Jonghe S, Vermeulen A, Vynckier A, et al. Modeling the time course of the tissue responses to intramuscular long-acting paliperidone palmitate nano-/microcrystals and polystyrene microspheres in the rat. Toxicol Pathol. 2015;44:189–210.

PubMed  Google Scholar 

Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20:86–100.

Article  CAS  PubMed  Google Scholar 

Paquette SM, Dawit H, Hickey MB, Merisko-liversidge E, Almarsson Ö, Deaver DR. Long-acting atypical antipsychotics: characterization of the local tissue response. Pharm Res. 2014;31:2065–77.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Williams DF. There is no such thing as a biocompatible material. Biomaterials. 2014;35:10009–14.

Article  CAS  PubMed  Google Scholar 

Van ’t Klooster GVJ, Hoeben E, Borghys H, Looszova A, Bouche M, Velsen F Van, et al. Pharmacokinetics and disposition of rilpivirine (TMC278) nanosuspension as a long-acting injectable antiretroviral formulation. 2010;54:2042–50.

Yue H, Wei W, Yue Z, Lv P, Wang L, Ma G, et al. Particle size affects the cellular response in macrophages. Eur J Pharm Sci. 2010;41:650–7.

Article  CAS  PubMed  Google Scholar 

De Meulder M, Vynckier A, van Heerden M, Darville N, Van den Mooter G, Sterkens P, et al. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats. J Pharm Sci. 2014;103:2072–87.

Article  PubMed  Google Scholar 

Hough D, Lindenmayer J-P, Gopal S, Melkote R, Lim P, Herben V, et al. Safety and tolerability of deltoid and gluteal injections of paliperidone palmitate in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:1022–31.

Article  CAS  PubMed  Google Scholar 

Berwaerts J, Liu Y, Gopal S, Nuamah I, Xu H, Savitz A, CD, SA, RB, et al. Efficacy and safety of the 3-month formulation of paliperidone palmitate vs placebo for relapse prevention of schizophrenia: a randomized clinical trial. JAMA Psychiatry. 2015;72.8:830–9.

Lindenmayer J. Long-acting injectable antipsychotics: focus on olanzapine pamoate. Neuropsychiatr Dis Treat. 2010;6:261–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spreen WR, Margolis DA, Pottage JC. Long-acting injectable antiretrovirals for HIV treatment and prevention. Curr Opin HIV AIDS. 2013;8:565–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verloes R, van ‘t Klooster G, Baert L, van Velsen F, Bouche M-P, Spittaels K, et al. TMC278 long acting–a parenteral nanosuspension formulation that provides sustained clinically relevant plasma concentrations in HIV-negative volunteers. Abstract TUPE0042, presented at the XVII International AIDS Conference. 2008.

McLennan DN, PCJH, and CSA. Subcutaneous drug delivery and the role of the lymphatics. Drug Discov Today Technol. 2005;2:89–96.

Oussoren C, Zuidema J, Crommelin DJA, Storm G. Lymphatic uptake and biodistribution of liposomes after subcutaneous injection I. Influence of the Anatomical Site of Injection. McLennan. 1997;7:85–99.

Samtani M, Vermeulen A, Stuyckens K. Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia. 2009;48:585–600.

Champion JA,, and Samir Mitragotri. Role of target geometry in phagocytosis. Proc Natl Acad Sci. 2006;103.13:4930–4.

Owens I, Donald E, Nicholas AP. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm. 2006;307(1):93–102.

Article  CAS  PubMed  Google Scholar 

Tabata Y, Yoshito Ikada. Macrophage phagocytosis of biodegradable microspheres composed of L‐lactic acid/glycolic acid homo‐and copolymers. J Biomed Mater Res. 1988;22.10:837–58.

Yáñez JA, RCM, SCL, FML, & DNM. Flip-flop pharmacokinetics–delivering a reversal of disposition: challenges and opportunities during drug development. Ther Deliv. 2011;2:643–72.

Correll CU, Kim E, Sliwa JK, Hamm W, Gopal S, Mathews M, et al. Pharmacokinetic characteristics of long-acting injectable antipsychotics for schizophrenia: an overview. CNS Drugs. Adis. 2021;35(1):39–59.

Schwendeman SP, Shah RB, Bailey BA, Schwendeman AS. Injectable controlled release depots for large molecules. J Controll Release. Elsevier. 2014;190:240–53.

Allmendinger A, Mueller R, Schwarb E, Chipperfield M, Huwyler J, Mahler HC, et al. Measuring tissue back-pressure - in vivo injection forces during subcutaneous injection. Pharm Res. 2015;32:2229–40.

Article  CAS  PubMed  Google Scholar 

Shahriar M, Rewanwar A, Rohilla P, Marston J. Understanding the effect of counterpressure buildup during syringe injections. Int J Pharm. 2021;602:120530.

Lee J, Gong Y, Bhoopathy S, DiLiberti CE, Hooker AC, Rostami-Hodjegan A, et al. Public workshop summary report on fiscal year 2021 generic drug regulatory science initiatives: data analysis and model-based bioequivalence. Clin Pharmacol Ther. John Wiley and Sons Inc. 2021;110(5):1190–5.

Pastorin G, Benetti C, Wacker MG. From in vitro to in vivo: a comprehensive guide to IVIVC development for long-acting therapeutics. Adv Drug Deliv Rev. Elsevier B.V.; 2023.

Department of Health and Human Services F and DAC for DE and R (CDER). Guidance for industry. extended release oral dosage forms: development, evaluation, and application of in vitro/in vivo correlations. 1999.

Neyens M, Crauwels HM, Perez-Ruixo JJ, Rossenu S. Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV. J Antimicrob Chemother. 2021;76:3255–62.

Article  CAS  PubMed  Google Scholar 

Gomeni R, Bressolle-Gomeni F. Modeling complex pharmacokinetics of long-acting injectable products using convolution-based models with nonparametric input functions. J Clin Pharmacol. 2021;61:1081–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomeni R, Bressolle-Gomeni F. Convolution-based approach for modeling the paliperidone extended release and long-acting injectable (LAI) PK of once-, and three-monthly products administration and for optimizing the development of new LAI products. J Pharmacokinet Pharmacodyn. 2022;50(2):89–96.

PubMed  PubMed Central  Google Scholar 

Gomeni RFB, MF. Response surface analysis and nonlinear optimization algorithm for maximization of clinical drug performance: application to extended-release and long-acting injectable paliperidone. J Clin Pharmacol. 2016;56:1296–306.

Article  CAS  PubMed